BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 13, 2000
View Archived Issues
Novartis and Noven enter marketing agreement for transdermal HRT
Read More
Company Profile: Naeja
Read More
Neurochem seeks U.K. approval to begin Fibrillex phase II/III trial
Read More
FDA grants fast track designation for RSR-13
Read More
First clinical trial begins for novel HDL therapy
Read More
Structural Bioinformatics reports small-molecule PTP1B inhibitors
Read More
FDA advises removal of phenylpropanolamine-containing products
Read More
Fujisawa continuing zenarestat development in Japan
Read More
NeoRx suspends STR trials
Read More
Cambridge Drug Discovery signs drug screening agreements with Avidex and RiboTargets
Read More
Cubist and Emisphere collaborate on oral delivery of daptomycin
Read More
Partnership formed for INOmax distribution in Japan
Read More
Novel antitumor compounds act by inhibiting VEGF receptor binding and function
Read More
Synthetic MMP inhibitor from Roche has promising antitumor/antiangiogenic activity
Read More
NCI-EORTC-AACR news: WP-769, a new oral doxorubicin analogue with an improved biological profile
Read More
Gelatinase-selective MMP inhibitor with potential clinical utility in cancer designed at Abbott
Read More
Structurally novel antitumor, antimetastatic and antiangiogenic agent with oral efficacy
Read More
Synthesis and preclinical evaluation of unique series of antitumor agents reported in Amsterdam
Read More
Trimetazidine analogue exerts significant hepatoprotective effects in I/R injury model in rats
Read More
First clinical results for UR-9825 discussed at Mycology meeting
Read More
Selective cGMP-PDE inhibitors synthesized at Nippon Soda
Read More
Novel series of anticoagulants patented by Kissei research team
Read More
Metalloproteinase inhibitors described by DuPont as particularly useful for arthritic conditions
Read More
Sankyo's new blood glucose-lowering agents described in recent patent
Read More
DuPont prepares aryl sulfonyl-based factor Xa inhibitors
Read More
Research at Neurogen leads to identification of new B2 receptor modulators
Read More
Synthesis and use of new NK3 receptor ligands presented by Neurogen
Read More
Shionogi patents several series of gelatinase A inhibitors
Read More